STP-1

N/A

Report date: 2025/12/11 17:56:25
First In Class

Base Information

Drug NameSTP-1
Drug Alias NameSTALICLA Therapeutic Package 1Ibudilast+BumetanideSTP-1STP1
ClassificationSmall molecules
Mechanisms of ActionPhosphodieterase 4 inhibitorsPhosphodiesterase 3 inhibitorsPhosphodiesterase 10A inhibitors +[12] 
TargetsPhosphodieterase 4Phosphodiesterase 3Solute carrier family 12 member 2 +[12] 
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes IbudilastBumetanide
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStalicla Sa
China Registration ClassN/A

Develop Information

Active CompaniesStalicla Sa
Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A